Annual CFF
$343.88 M
+$309.54 M+901.23%
December 31, 2024
Summary
- As of March 12, 2025, IMCR annual cash flow from financing activities is $343.88 million, with the most recent change of +$309.54 million (+901.23%) on December 31, 2024.
- During the last 3 years, IMCR annual CFF has risen by +$55.70 million (+19.33%).
- IMCR annual CFF is now at all-time high.
Performance
IMCR Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
-$51.51 M
-$51.71 M-26115.66%
December 31, 2024
Summary
- As of March 12, 2025, IMCR quarterly cash flow from financing activities is -$51.51 million, with the most recent change of -$51.71 million (-26115.66%) on December 31, 2024.
- Over the past year, IMCR quarterly CFF has stayed the same.
- IMCR quarterly CFF is now -113.01% below its all-time high of $396.01 million, reached on March 31, 2024.
Performance
IMCR Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$343.88 M
-$57.77 M-14.38%
December 31, 2024
Summary
- As of March 12, 2025, IMCR TTM cash flow from financing activities is $343.88 million, with the most recent change of -$57.77 million (-14.38%) on December 31, 2024.
- Over the past year, IMCR TTM CFF has stayed the same.
- IMCR TTM CFF is now -18.94% below its all-time high of $424.22 million, reached on March 31, 2024.
Performance
IMCR TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
IMCR Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +901.2% | 0.0% | 0.0% |
| 3 y3 years | +19.3% | -583.1% | +19.3% |
| 5 y5 years | +375.8% | -414.1% | -15.0% |
IMCR Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +901.2% | -113.0% | at low | -18.9% | >+9999.0% |
| 5 y | 5-year | at high | +901.2% | -113.0% | at low | -18.9% | >+9999.0% |
| alltime | all time | at high | >+9999.0% | -113.0% | at low | -18.9% | >+9999.0% |
Immunocore Holdings Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $343.88 M(+901.2%) | -$51.51 M(<-9900.0%) | $343.88 M(-14.4%) |
| Sep 2024 | - | $198.00 K(-124.2%) | $401.65 M(-2.5%) |
| Jun 2024 | - | -$818.00 K(-100.2%) | $411.82 M(-2.9%) |
| Mar 2024 | - | $396.01 M(+6232.1%) | $424.22 M(+1135.1%) |
| Dec 2023 | $34.35 M(-76.4%) | $6.25 M(-39.7%) | $34.35 M(-22.6%) |
| Sep 2023 | - | $10.38 M(-10.4%) | $44.39 M(-73.2%) |
| Jun 2023 | - | $11.58 M(+88.6%) | $165.43 M(+7.9%) |
| Mar 2023 | - | $6.14 M(-62.3%) | $153.33 M(+5.4%) |
| Dec 2022 | $145.44 M | $16.30 M(-87.6%) | $145.44 M(+4.0%) |
| Sep 2022 | - | $131.41 M(<-9900.0%) | $139.80 M(-8699.5%) |
| Jun 2022 | - | -$518.40 K(-70.4%) | -$1.63 M(+20.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$1.75 M(-116.4%) | -$1.35 M(-100.5%) |
| Dec 2021 | $288.19 M(+82.4%) | $10.66 M(-206.4%) | $288.19 M(-28.8%) |
| Sep 2021 | - | -$10.02 M(+4014.7%) | $404.69 M(-2.4%) |
| Jun 2021 | - | -$243.50 K(-100.1%) | $414.71 M(+0.3%) |
| Mar 2021 | - | $287.79 M(+126.3%) | $413.45 M(+161.7%) |
| Dec 2020 | $158.01 M(+118.6%) | $127.16 M(>+9900.0%) | $158.01 M(+412.3%) |
| Sep 2020 | - | $5900.00(-100.4%) | $30.84 M(+0.0%) |
| Jun 2020 | - | -$1.51 M(-104.7%) | $30.84 M(-4.7%) |
| Mar 2020 | - | $32.35 M | $32.35 M |
| Dec 2019 | $72.28 M(>+9900.0%) | - | - |
| Dec 2018 | $128.20 K | - | - |
FAQ
- What is Immunocore Holdings annual cash flow from financing activities?
- What is the all time high annual CFF for Immunocore Holdings?
- What is Immunocore Holdings annual CFF year-on-year change?
- What is Immunocore Holdings quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Immunocore Holdings?
- What is Immunocore Holdings quarterly CFF year-on-year change?
- What is Immunocore Holdings TTM cash flow from financing activities?
- What is the all time high TTM CFF for Immunocore Holdings?
- What is Immunocore Holdings TTM CFF year-on-year change?
What is Immunocore Holdings annual cash flow from financing activities?
The current annual CFF of IMCR is $343.88 M
What is the all time high annual CFF for Immunocore Holdings?
Immunocore Holdings all-time high annual cash flow from financing activities is $343.88 M
What is Immunocore Holdings annual CFF year-on-year change?
Over the past year, IMCR annual cash flow from financing activities has changed by +$309.54 M (+901.23%)
What is Immunocore Holdings quarterly cash flow from financing activities?
The current quarterly CFF of IMCR is -$51.51 M
What is the all time high quarterly CFF for Immunocore Holdings?
Immunocore Holdings all-time high quarterly cash flow from financing activities is $396.01 M
What is Immunocore Holdings quarterly CFF year-on-year change?
Over the past year, IMCR quarterly cash flow from financing activities has changed by $0.00 (0.00%)
What is Immunocore Holdings TTM cash flow from financing activities?
The current TTM CFF of IMCR is $343.88 M
What is the all time high TTM CFF for Immunocore Holdings?
Immunocore Holdings all-time high TTM cash flow from financing activities is $424.22 M
What is Immunocore Holdings TTM CFF year-on-year change?
Over the past year, IMCR TTM cash flow from financing activities has changed by $0.00 (0.00%)